What makes a good (and bad) pharmaceutical forecast model
Having good forecast models is critical for effective and efficient decision-making. This will deliver accurate and reliable insights to help support business objectives and drive brand or company growth, highlight risk, and quantify opportunity. This article explores the key ingredients needed for developing good pharmaceutical forecast models. It’s widely accepted that there is no such […]
Mastering Long-Range Planning: From Challenges to Actionable Solutions
Are you in the midst of yet another challenging Long Range Planning (LRP) cycle and wondering if there is a better way? If the answer is yes, may I suggest you register for our upcoming webinar. In our first webinar on this topic, we talked about some of the biggest challenges in LRP. In this […]
How can you Improve Efficiencies in your Long-Range Planning?
No element of pharmaceutical forecasting is easy but there’s a particular challenge in long-range planning. The range of components involved results in a greater degree of complexity which can allow inaccuracies to creep in very easily. We covered some of the key challenges in a recent webinar, The Forecaster’s Guide to Long-Range Planning, which you […]
Three Things We Learned in Our Orphan Drugs Webinar
Our recent orphan drugs webinar provided a wealth of insights into the current state and future of the orphan drug market. It was based on our annual report (which is available here) and if you missed it, I recommend taking the time to watch the on-demand version. Our panel included the report’s author, Melanie Senior […]
The Pharma Files: What Have you Missed?
As you probably know, Evaluate has an incredibly rich and comprehensive set of data and insight about the pharma market. This means we’re able to produce some really valuable reports, webinars and articles that provide insight around the most exciting areas of the industry. And we create rather a lot of them, which can make […]
Is it Time to Rethink Orphan Drugs?
If you follow Evaluate’s regular white papers and blogs, you may be familiar with our annual report that investigates the state of the orphan drug market. I’ve been involved in analyzing that data for the past three years, and have just finished the process for this year’s report which will be published soon. One of […]
How Pharma Professionals Rate Our Forecasting Training
Formal training is essential for stakeholder teams looking to enhance their forecasting expertise. By deepening their understanding of fundamental principles, methodologies, and process steps, teams can approach forecasting with greater confidence and ensure they are applying best practices effectively. However, learning should not be a passive process. We believe self-assessment is a powerful tool for […]
Three Things we Learned in our Long-Range Planning Webinar
How’s your long-range planning going? If you’re tasked with the forecasting processes for a pharma or biotech company, you may be in the midst of this annual cycle at the moment. Long-range planning (or LRP as the cool forecasters call it) provides a really important guide to company performance over five to 10 years. Like […]
Overcoming Challenges in Long-Range Planning Forecasting
Long-Range Planning (LRP) is no easy feat. As someone who has worked extensively in this area, I’ve seen firsthand the complexities and challenges that professionals face – whether it’s managing diverse portfolios, navigating cross-functional dynamics, or working with tools that just don’t fit the bill. That’s why I’m thrilled to be taking part in this […]
Three Things we Learned in our 2025 Preview Webinar
The first Evaluate webinar of the year is in the bag. Based on our 2025 Preview report, this session brought together three of our industry experts to discuss what the year ahead might hold for pharma. They may not have had a crystal ball, but they had plenty of detailed data and insight which is […]
